Author correction to"Neutralization of SARSCoV-2 pseudovirus using ACE2-engineered extracellular vesicles"[Acta Pharmaceutica Sinica B 12(2022)1523-1533]  

作　　者：Canhao Wu Qin Xua Huiyuan Wang Bin Tu Jiaxin Zeng Pengtei Zhao Mingjie Shi Hong Qiu Yongzhuo Huang 

机构地区：[1]Artemisinin Research Center,First Clinical School,Guangzhou University of Chinese Medicine,Guangzhou 510450,China [2]State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China [3]Zhongshan Institute for Drug Discovery,SIMM,CAS,Zhongshan 528437,China [4]Center of Clinical Pharmacology,the Second Affliated Hospital of Zhejiang University,School of Medicine,Hangzhou 310009,China [5]NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients,Shanghai 201203,China [6]Taizhou University,School of Advanced Study,Institute of Natural Medicine and Health Product,Taizhou 3180,China

出　　处：《Acta Pharmaceutica Sinica B》2023年第11期4664-4666,共3页药学学报（英文版）

摘　　要：The authors regret in the initially published version of this article,there is a misapplied image in Fig.3C.The corrected Fig.3 is provided below.

关 键 词：CORRECTION initially ACE2 

分 类 号：G23[文化科学]